The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: doxorubicin hydrochloride     Quarter: 2016Q3

Total Records: 406     Number of Pages: 21

DRUGNAME PT EventCount
DOXORUBICIN HYDROCHLORIDE. Encephalopathy 4
DOXORUBICIN HYDROCHLORIDE. Epstein-Barr virus infection 4
DOXORUBICIN HYDROCHLORIDE. Exposure during pregnancy 4
DOXORUBICIN HYDROCHLORIDE. Hepatocellular carcinoma 4
DOXORUBICIN HYDROCHLORIDE. Histiocytosis haematophagic 4
DOXORUBICIN HYDROCHLORIDE. Hypocalcaemia 4
DOXORUBICIN HYDROCHLORIDE. Malignant neoplasm progression 4
DOXORUBICIN HYDROCHLORIDE. Myocardial infarction 4
DOXORUBICIN HYDROCHLORIDE. Neurotoxicity 4
DOXORUBICIN HYDROCHLORIDE. Oesophagitis 4
DOXORUBICIN HYDROCHLORIDE. Osteonecrosis 4
DOXORUBICIN HYDROCHLORIDE. Pneumonitis 4
DOXORUBICIN HYDROCHLORIDE. Premature baby 4
DOXORUBICIN HYDROCHLORIDE. Pulmonary toxicity 4
DOXORUBICIN HYDROCHLORIDE. Tachycardia 4
DOXORUBICIN HYDROCHLORIDE. Venoocclusive disease 4
DOXORUBICIN HYDROCHLORIDE. Weight decreased 4
DOXORUBICIN HYDROCHLORIDE. Abdominal pain 3
DOXORUBICIN HYDROCHLORIDE. Ascites 3
DOXORUBICIN HYDROCHLORIDE. Aspartate aminotransferase increased 3

Total Records: 406     Number of Pages: 21